← All organizations

Exeltis

For profitContributed to NMEWebsite ↗

Also known as: Chemo Research | Chemo Research SL | Chemo Research S.L. | CHEMO RESEARCH SL | Exeltis | Exeltis France | Exeltis Turkey | Exeltis USA | EXELTIS USA INC | XIROMED | Xiromed LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Jan 19, 2026

Timeline

1970s

Jun 1, 1971
Exeltis— Founded

2010s

Mar 24, 2014
metronidazole— NDA Secondary Org
Nov 13, 2014
Embil Pharmaceutical Co. Ltd— Acquired
Aug 29, 2017
benznidazole— NDA Organization

2020s

Aug 13, 2021
fulvestrant— Marketing Organization

Drugs by trial phase (15 distinct, 16 trials)

Phase 4 (6 own, 0 via acquisition)

Phase 3 (7 own, 1 via acquisition)

Phase 2 (0 own, 1 via acquisition)

miconazole

Indications

Approved for

Chagas Disease

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Embil Pharmaceutical Co. Ltd

Recent trials (19)

NCT06856174CollaboratorPhase 4Jan 19, 2026
NCT06856174CollaboratorPhase 4Jan 19, 2026
NCT06389474CollaboratorPhase 3Aug 17, 2024
NCT06019533Lead sponsorPhase 3Aug 9, 2023
NCT06254664Lead sponsorPhase 1Oct 3, 2022
NCT05986591CollaboratorPhase 3Aug 17, 2022
NCT05986591Lead sponsorPhase 3Aug 17, 2022
NCT05461573CollaboratorPhase 3Aug 2, 2022
NCT05461573Study directorPhase 3Aug 2, 2022
NCT05361369Lead sponsorPhase 1May 9, 2022
NCT05303636CollaboratorPhase 4Mar 28, 2022
NCT05303636Study directorPhase 4Mar 28, 2022
NCT06056947CollaboratorPhase 3Jul 20, 2020
NCT03945513Study directorPhase 3Aug 31, 2019
NCT03945513CollaboratorPhase 3Aug 31, 2019

Details

Founded: Florham Park, NJ, US Jun 1, 1971
First NDA: Aug 29, 2017
Last known activity: Jan 19, 2026

Designations held

Orphan drug
Priority review
Accelerated approval